4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-22-016164
CEO sold 50,000 shares at an average $37.98 ($1,898,899)
- CEO acquired 59,450 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2022-04-28 | Option exercise | +12,246 | $7.22 | $88,416 | 1,101,316 | D |
| Evans John M. CEO | 2022-04-28 | Option exercise | +47,204 | $1.03 | $48,620 | 1,148,520 | D |
| Evans John M. CEO | 2022-04-28 | Sale | −3,900 | $36.59 | $142,701 | 1,144,620 | D |
| Evans John M. CEO | 2022-04-28 | Sale | −13,655 | $37.48 | $511,789 | 1,130,965 | D |
| Evans John M. CEO | 2022-04-28 | Sale | −6,842 | $38.32 | $262,185 | 1,124,123 | D |
| Evans John M. CEO | 2022-04-28 | Sale | −4,503 | $39.49 | $177,823 | 1,119,620 | D |
| Evans John M. CEO | 2022-04-28 | Sale | −1,100 | $40.73 | $44,803 | 1,118,520 | D |
| Evans John M. CEO | 2022-04-28 | Sale | −6,450 | $36.98 | $238,521 | 156,550 | I |
| Evans John M. CEO | 2022-04-28 | Sale | −7,745 | $37.84 | $293,071 | 148,805 | I |
| Evans John M. CEO | 2022-04-28 | Sale | −3,100 | $38.75 | $120,125 | 145,705 | I |
| Evans John M. CEO | 2022-04-28 | Sale | −2,348 | $39.73 | $93,286 | 143,357 | I |
| Evans John M. CEO | 2022-04-28 | Sale | −357 | $40.88 | $14,594 | 143,000 | I |
| Derivatives | |||||||
| Evans John M. CEO | 2022-04-28 | Option exercise · Stock Option (Right to Buy) | −12,246 | 210,754 | D | ||
| Evans John M. CEO | 2022-04-28 | Option exercise · Stock Option (Right to Buy) | −47,204 | 237,141 | D | ||
| Open-market sales · 50,000 sh · avg $37.98 · $1,898,899 | |||||||
Loading xslF345X03/doc4.xml…